Comparative efficacy of ceftolozane-tazobactam versus ceftazidime-avibactam for Pseudomonas aeruginosa infections: a GRADE-assessed systematic review and meta-analysis
Abstract
Background: Infections caused by multidrug-resistant/difficult-to-treat (MDR/DTR) Pseudomonas aeruginosa present a significant challenge for treatment. Ceftolozane-tazobactam (C/T) and ceftazidime-avibactam (C/A) are important options that combine β-lactam and β-lactamase inhibitors, but their effectiveness compared to each other is still unclear.
Methods: We performed a systematic review and meta-analysis, evaluated by Grading of Recommendations Assessment, Development, and Evaluation (GRADE), of comparative observational studies that included hospitalized adults with confirmed MDR/DTR P. aeruginosa infections up to 10 October 2025 (English only). Studies comparing C/T directly with C/A and matched therapies were included. We used random-effects Mantel-Haenszel models to calculate pooled risk ratios (RR) with 95% confidence intervals (CIs), and we assessed heterogeneity with I 2. We reviewed the certainty of evidence using GRADE.
Results: Six observational cohorts (n = 1161) met our criteria. There were no significant differences between C/T and C/A for clinical success (RR: 1.07, 0.89-1.29; I 2 = 40%), 30-day all-cause mortality (RR: 1.02, 95% CI: 0.83-1.27; I 2 = 0%), 30-day recurrence (RR: 0.85, 0.46-1.57; I 2 = 48%), 90-day recurrence (RR: 0.80, 0.63-1.02; I 2 = 0%; P = 0.08), emergence of resistance (RR: 0.73, 0.30-1.81; I 2 = 84%), and microbiological response failure (RR: 0.91, 0.66-1.26; I 2 = 8%). There was a non-significant trend that slightly favored C/T for…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,161 participants or records.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.